Gatekeeper European 005

NCT ID: NCT00229086

Last Updated: 2008-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

55 participants

Study Classification

OBSERVATIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of the Gatekeeper System in the treatment of patients with Gastroesophageal Reflux Disease (GERD) who already have been treated under study protocols Endo 2000-03 and Endo 2000-04

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

GERD

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Gatekeeper Reflux Repari System (Device)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects must have been part of the Endo 2000-03 or Endo 2000-04 clinical study
* Subjects who have been informed of the nature of the long-term follow-up study and have agreed to its participation and provided Informed Consent

Exclusion Criteria

* Underwent another endoscopic or surgical treatment for GERD (except re-intervention with Gatekeeper)
* Developed other medical illness that may cause the subject to be non-compliant
* Extensive Barrett's Esophagus (\>2 cm)
* Unable or unwilling to cooperate with the study procedures
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

MedtronicNeuro

INDUSTRY

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medtronic GU Investigator

Role: PRINCIPAL_INVESTIGATOR

MedtronicNeuro

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Contact Medtronic for specific site information

Minneapolis, Minnesota, United States

Site Status

Contact Medtronic for specific location

Tolochenaz, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MGU-004

Identifier Type: -

Identifier Source: org_study_id